What Are the Different Budesonide Side Effects?

For many years, AstraZeneca has been committed to relieving pain for the majority of rhinitis patients. As early as 1983, the use of the Renault Coulter pressure metered dose inhalation device (pMDI) has been used to treat rhinitis, but it was found that when using the pressure metered dose inhalation device, a part of the drug was retained in the container, and the drug that actually reached the nasal mucosa The dosage is only 67%, and the pressure dosing device requires a driver (such as Freon) and a lubricant, which leads to a high incidence of side effects; therefore, an aqueous suspension (Budesonide nasal spray) has been developed and is non-preservative Additives, the incidence of side effects is small, when the drug is sprayed into the nasal cavity, it will change from a water-like liquid to a thick, gel-like liquid, which can cover the nasal mucosa well, and the dose reaching the nasal mucosa is 100%; Recent studies have found the best dose for rhinitis; therefore, AstraZeneca adjusted the package dose and launched a new package of budesonide in August 2002. ^[1]

Budesonide spray

Over the years

[Manufacturer] AstraZeneca AB, s-151 85, Sodertije Sweden

[Category of action] This product is an over-the-counter drug for ENT medicine.

[Pharmacological action] This product is

Adverse reactions to local irritation occur in about 5% of patients. Common (> 1/100): Airway: local irritation, slight bloody secretions, nosebleeds. Rare (1/1000): Systemic: Angioedema. Skin: hives, rash, dermatitis, itching. Airway: Nasal septum perforation and mucosal ulcers. Rapid or delayed allergic reactions including urticaria, rash, dermatitis, angioedema, and pruritus have been reported. Very few patients develop mucosal ulcers and perforation of the nasal septum after glucocorticoid administration in the nasal cavity. The cause of these adverse reactions, which may be caused by glucocorticoids, these diseases, or other factors, is unknown.

1. After using this product for 14 days, the symptoms have not improved, please consult your doctor.

2. Self-treatment time should not exceed 3 months. If more than 3 months are needed, it should be used under the guidance of a physician.

3 With long-term use of high doses, systemic effects of glucocorticoids may occur. Children and adolescents receiving long-term treatment with this product may cause growth retardation and should be used under the guidance of a physician.

4 Use with caution in patients with nasal fungal infections and herpes.

5. Those who use systemic glucocorticoids instead of this product should use it under the guidance of a physician.

6. Use with caution in patients with tuberculosis.

7. This product is for nasal use only. Do not contact eyes. If contact with eyes, please wash with water immediately.

8.6 Children under 6 years are not recommended to use this product.

9. Pregnant and lactating women should avoid using this product.

10 If overdose or serious adverse reactions occur, consult a doctor immediately.

11. Disable when the characteristics of this product change.

12. Children must use under adult supervision.

13. Keep this medicine out of the reach of children.